These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37981330)

  • 1. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
    Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
    Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women.
    Nakamura K; Nanri H; Hara M; Higaki Y; Imaizumi T; Taguchi N; Sakamoto T; Horita M; Shinchi K; Tanaka K
    Environ Health Prev Med; 2011 Jan; 16(1):52-60. PubMed ID: 21432217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Kurotani K; Sasaki N; Murakami T; Shimizu C; Shimizu M; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Nagahama S; Uehara A; Yamamoto M; Tomita K; Imai T; Nishihara A; Kochi T; Eguchi M; Miyamoto T; Hori A; Kuwahara K; Akter S; Kashino I; Kabe I; Liu W; Mizoue T; Kunugita N; Dohi S;
    BMC Public Health; 2016 Mar; 16():220. PubMed ID: 26939609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issue of Waist Circumference for the Diagnosis of Metabolic Syndrome Regarding Arterial Stiffness: Possible Utility of a Body Shape Index in Middle-Aged Nonobese Japanese Urban Residents Receiving Health Screening.
    Nagayama D; Watanabe Y; Yamaguchi T; Suzuki K; Saiki A; Fujishiro K; Shirai K
    Obes Facts; 2022; 15(2):160-169. PubMed ID: 35008086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome across Europe: different clusters of risk factors.
    Scuteri A; Laurent S; Cucca F; Cockcroft J; Cunha PG; Mañas LR; Mattace Raso FU; Muiesan ML; Ryliškytė L; Rietzschel E; Strait J; Vlachopoulos C; Völzke H; Lakatta EG; Nilsson PM;
    Eur J Prev Cardiol; 2015 Apr; 22(4):486-91. PubMed ID: 24647805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
    Dehghan A; Jahangiry L; Khezri R; Jafari A; Pezeshki B; Rezaei F; Aune D
    BMC Endocr Disord; 2024 Jun; 24(1):95. PubMed ID: 38915041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study.
    Seo JA; Kim BG; Cho H; Kim HS; Park J; Baik SH; Choi DS; Park MH; Jo SA; Koh YH; Han C; Kim NH
    BMC Public Health; 2009 Dec; 9():443. PubMed ID: 19951442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric Cutoffs for Increased Cardiometabolic Risk Among Lebanese Adults: A Cross-Sectional Study.
    Nasreddine L; Bachir N; Kharroubi S; Chamieh MC; Mehio Sibai A; Hwalla N; Naja F
    Metab Syndr Relat Disord; 2019 Dec; 17(10):486-493. PubMed ID: 31566527
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of wrist circumference for predicting the presence of coronary artery disease and metabolic syndrome.
    Hajsadeghi S; Firouzi A; Bahadoran P; Hassanzadeh M
    Indian Heart J; 2016 Dec; 68 Suppl 3(Suppl 3):S5-S9. PubMed ID: 28038723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes.
    Delautre A; Chantrel F; Dimitrov Y; Klein A; Imhoff O; Muller C; Schauder N; Hannedouche T; Krummel T
    BMC Nephrol; 2020 Aug; 21(1):343. PubMed ID: 32792012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric cut-points for discriminating diabetes and the metabolic syndrome among Arabs and Asians: the Kuwait Diabetes Epidemiology Program.
    Oguoma VM; Coffee NT; Alsharrah S; Abu-Farha M; Al-Refaei FH; Alkandari A; Al-Mulla F; Daniel M
    Br J Nutr; 2022 Jan; 127(1):92-102. PubMed ID: 33658089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study.
    Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Ono Y; Nishimura K; Okayama A; Miyamoto Y
    Atherosclerosis; 2011 Jul; 217(1):201-6. PubMed ID: 21481396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.